Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-08-2006 | Original article

^123/125I-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice

Authors: Veerle Kersemans, Bart Cornelissen, Ken Kersemans, Matthias Bauwens, Rudi A. Dierckx, Bart De Spiegeleer, John Mertens, Guido Slegers

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2006

Abstract

Purpose

In vitro in the R1M cell model and in vivo in the R1M tumour-bearing athymic model, both [¹²³I]-2-iodo-L-phenylalanine and [¹²³I]-2-iodo-D-phenylalanine have shown promising results as tumour diagnostic agents for SPECT. In order to compare these two amino acid analogues and to examine whether the observed characteristics could be generalised, both isomers were evaluated in various tumour models.

Methods

Transport type characterisation in vitro in A549, A2058, C6, C32, Capan2, EF43fgf4, HT29 and R1M cells with [¹²³I]-2-iodo-L-phenylalanine was performed using the method described by Shotwell et al. Subsequently, [¹²³I]-2-iodo-L-phenylalanine and [¹²³I]-2-iodo-D-phenylalanine tumour uptake and biodistribution were evaluated using dynamic planar imaging and/or dissection in A549, A2058, C6, C32, Capan2, EF43fgf4, HT29 and R1M inoculated athymic mice. Two-compartment blood modelling of the imaging results was performed.

Results

In vitro testing demonstrated that [¹²³I]-2-iodo-L-phenylalanine was transported in all tumour cell lines by LAT1. In all tumour models, the two amino acid analogues showed the same general biodistribution characteristics: high and specific tumour uptake and renal tracer clearance. Two-compartment modelling revealed that the D-isomer showed a faster blood clearance together with a faster distribution to the peripheral compartment in comparison with [¹²³I]-2-iodo-L-phenylalanine.

Conclusion

[¹²³I]-2-iodo-L-phenylalanine and its D-isomer are promising tumour diagnostic agents for dynamic planar imaging. They showed a high and similar uptake in all tested tumours. [¹²³I]-2-iodo-D-phenylalanine showed better tracer characteristics concerning radiation dose to other organs.

Hustinx R, Lemaire C, Jerusalem G, Moreau P, Cataldo D, Duysinx B, et al. Whole-body tumor imaging using PET and 2-¹⁸F-fluoro-L-tyrosine: preliminary evaluation and comparison with¹⁸F-FDG. J Nucl Med 2003;44:533–539PubMed

Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA, et al. Radiolabelled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432–445PubMed

Lahoutte T, Mertens J, Caveliers V, Franken PR, Everaert H, Bossuyt A, et al. Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain. J Nucl Med 2003;44:1489–1494PubMed

Isselbacher KJ. Sugar and amino acid transport by cells in culture—differences between normal and malignant cells. Seminars in Medicine of the Beth Israel Hospital 1972;286:929–933

Jager PL, De Vries EGE, Piers DA, Timmer-Bosscha H. Uptake mechanisms of L-3-[¹²⁵I]-iodo-alpha-methyl-tyrosine in human small-cell lung cancer cell line: comparison with L-1-[¹⁴C]-tyrosine. Nucl Med Commun 2001;22:87–96CrossRefPubMed

Tamemasa O, Goto R, Suzuki T. Preferential incorporation of some¹¹C-labeled D-amino acids into tumor bearing animals. Gann 1978;69:517–523PubMed

Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, et al. Human L-type amino acid transport system 1 (LAT1): characterisation of function and expression in tumour cell lines. Biochim Biophys Acta 2001;1514:291–302PubMedCrossRef

Yang H, Zheng G, Peng X, Qiang B, Yuan J. D-Amino acids and D-Tyr-tRNA^Tyr deacylase: stereospecificity of the translation machine revisited. FEBS Letters 2003;552:95–98CrossRefPubMed

Kersemans B, Cornelissen K, et al. In Vivo Characterization of 123/1251-2-iodo-LPhenylalanine in an RIM Rhabdomyosarcoma Athymic Mouse Model as a Potential Tumor Tracer for SPECT. J Nucl Med 2005;46:532-539PubMed

10.

Kersemans V, Kersemans K, Cornelissen B, et al. In vivo evaluation of [I-123]-2-iodo-D-phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool. Eur J Nucl Med 2004;31:S219 (meeting abstract)

11.

Shotwell MA, Jayme DW, Kilberg MS, Oxender DL. Neutral amino acid transport systems in Chinese hamster ovary cells. J Biol Chem 1981;256:5422–5427PubMed

12.

Mertens JJR, Kersemans V, Lahoutte T, Bauwens M, Joos C, Kersemans K, et al. Radioiodo-D-2-I-phenylalanine a new tumour specific tracer for diagnosis and systemic radionuclide therapy. Eur J Nucl Med Mol Imaging 2004;31:S220

13.

Waterton JC, Alott CP, Pickfort R, et al. Assessment of mouse tumour xenograft volumes in vivo by ultrasound imaging, MRI and calliper measurement. In: Faulkner K, Carey B, Crellin A, Harrison RM, editors. Proceedings of the 19th LH Gray Conference: Quantitative imaging in oncology. London; 1997 p. 146–149

14.

Cornelissen B, Kersemans V, Jans L, Staelens L, Oltenfreiter R, Thonissen T, et al. Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice. Br J Radiol 2005;78:338–342CrossRefPubMed

15.

Thie JA. Understanding the standardized uptake value, its methods and implications for usage. J Nucl Med 2004;45:1431–1434PubMed

16.

Langen KJ, Pauleit D, Coenen HH. 3-[¹²³I]iodo-alpha-methyl-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2002;29:625–631CrossRefPubMed

17.

Vekeman M, Chavatte K, Lahoutte T, et al. L-[2-radioiodo] tyrosine, a new potential protein synthesis and tumour tracer for SPECT: radiosynthesis and biodistribution in rodent [abstract]. Eur J Nucl Med 1999;26:S43CrossRefPubMed

18.

Samnick S, Hellwig D, Bader JB, Romeike BF, Moringlane JR, Feiden W, et al. Initial evaluation of the feasibility of single photon emission tomography with p-[¹²³I]iodo-L-phenylalanine for routine brain tumor imaging. Nucl Med Commun 2002;23:121–130CrossRefPubMed

19.

Samnick S, Richter S, Romeike BF, Heimann A, Feiden W, Kempski O, et al. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats. Eur J Nucl Med 2000;27:1543–1551CrossRefPubMed

20.

Keyaerts M, Lahoutte T, Everaert H, et al. Initial clinical evaluation of 123-I-2-iodo-tyrosine in patients with brain tumours. (meeting abstract EANM 2005, Istanbul)

Title: 123/125I-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice
Authors: Veerle Kersemans
Bart Cornelissen
Ken Kersemans
Matthias Bauwens
Rudi A. Dierckx
Bart De Spiegeleer
John Mertens
Guido Slegers
Publication date: 01-08-2006
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2006
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-005-0043-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

^123/125I-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2006

Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy

Lymphatic mapping to tailor selective lymphadenectomy in cN0 tongue carcinoma: beyond the sentinel node concept

Detection of widespread neurolymphomatosis with 18F-FDG PET

[18F]FETO: metabolic considerations

Comparative assessment of18F-fluorodeoxyglucose PET and99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction

Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusion